CD44 and ovarian carcinoma: Indeed, it has been demonstrated that peritoneal cells produce both extracellular matrix molecule, hyaluronan (HA) and the HA receptor, CD44 [12–14], and can promote ovarian cancer motility by increasing their HA production in co-culture with ovarian cancer cells [14].